Hematological Malignancies Clinical Trials in Guangzhou
2 recruitingGuangzhou, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Hematological Malignancies
Janssen Research & Development, LLC510 enrolled78 locationsNCT04634552
Recruiting
Phase 1
A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
Hematological Malignancies
Hutchmed132 enrolled16 locationsNCT06387082